AMNEAL PHARMACEUTICALS, INC. Restructuring Charges
AMNEAL PHARMACEUTICALS, INC. (AMRX) reported Restructuring Charges of $554.00 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:RestructuringCharges · last filed 2026-08-06
- AMNEAL PHARMACEUTICALS, INC. restructuring charges for the quarter ending 2026-06-30 was $554.00K, a 45.90% decline year-over-year.
- AMNEAL PHARMACEUTICALS, INC. restructuring charges for the quarter ending 2026-03-31 was $650.00K, a 13.84% increase year-over-year.
- AMNEAL PHARMACEUTICALS, INC. restructuring charges for the quarter ending 2025-12-31 was $2.47M, a 401.01% increase year-over-year.
- AMNEAL PHARMACEUTICALS, INC. restructuring charges for the quarter ending 2025-09-30 was $143.00K, a 16.86% decline year-over-year.
- AMNEAL PHARMACEUTICALS, INC. restructuring charges for fiscal 2025 was $4.21M, a 78.68% increase from fiscal 2024.
- AMNEAL PHARMACEUTICALS, INC. restructuring charges for fiscal 2024 was $2.35M, a 34.65% increase from fiscal 2023.
- AMNEAL PHARMACEUTICALS, INC. restructuring charges for fiscal 2023 was $1.75M, a 23.08% increase from fiscal 2022.
- AMNEAL PHARMACEUTICALS, INC. restructuring charges for fiscal 2022 was $1.42M, a 23.48% decline from fiscal 2021.
| Period end | Restructuring Charges 3 month | Restructuring Charges 6 month | Restructuring Charges 9 month | Restructuring Charges 12 month |
|---|---|---|---|---|
| 2026-06-30 | $554.00K 10-Q · filed 2026-08-06 | $1.20M 10-Q · filed 2026-08-06 | $3.67M derived: sum of 3 quarters · filed 2026-08-06 | $3.82M derived: sum of 4 quarters · filed 2026-08-06 |
| 2026-03-31 | $650.00K 10-Q · filed 2026-05-07 | $3.12M derived: sum of 2 quarters · filed 2026-05-07 | $3.26M derived: sum of 3 quarters · filed 2026-05-07 | $4.29M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-12-31 | $2.47M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27 | $2.61M derived: sum of 2 quarters · filed 2026-02-27 | $3.64M derived: sum of 3 quarters · filed 2026-08-06 | $4.21M 10-K · filed 2026-02-27 |
| 2025-09-30 | $143.00K 10-Q · filed 2025-11-06 | $1.17M derived: sum of 2 quarters · filed 2026-08-06 | $1.74M 10-Q · filed 2025-11-06 | $2.23M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-06-30 | $1.02M 10-Q · filed 2026-08-06 | $1.59M 10-Q · filed 2026-08-06 | $2.09M derived: sum of 3 quarters · filed 2026-08-06 | $2.26M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-03-31 | $571.00K 10-Q · filed 2026-05-07 | $1.06M derived: sum of 2 quarters · filed 2026-05-07 | $1.24M derived: sum of 3 quarters · filed 2026-05-07 | $1.46M derived: sum of 4 quarters · filed 2026-05-07 |
| 2024-12-31 | $493.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27 | $665.00K derived: sum of 2 quarters · filed 2026-02-27 | $885.00K derived: sum of 3 quarters · filed 2026-02-27 | $2.35M 10-K · filed 2026-02-27 |
| 2024-09-30 | $172.00K 10-Q · filed 2025-11-06 | $392.00K derived: sum of 2 quarters · filed 2025-11-06 | $1.86M 10-Q · filed 2025-11-06 | $1.98M derived: sum of 4 quarters · filed 2026-02-27 |
| 2024-06-30 | $220.00K 10-Q · filed 2025-08-07 | $1.69M 10-Q · filed 2025-08-07 | $1.80M derived: sum of 3 quarters · filed 2026-02-27 | $2.85M derived: sum of 4 quarters · filed 2026-02-27 |
| 2024-03-31 | $1.47M 10-Q · filed 2025-05-07 | $1.58M derived: sum of 2 quarters · filed 2026-02-27 | $2.63M derived: sum of 3 quarters · filed 2026-02-27 | $2.71M derived: sum of 4 quarters · filed 2026-02-27 |
| 2023-12-31 | $114.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27 | $1.16M derived: sum of 2 quarters · filed 2026-02-27 | $1.24M derived: sum of 3 quarters · filed 2026-02-27 | $1.75M 10-K · filed 2026-02-27 |
| 2023-09-30 | $1.04M 10-Q · filed 2024-11-12 | $1.13M derived: sum of 2 quarters · filed 2024-11-12 | $1.64M 10-Q · filed 2024-11-12 | $1.74M derived: sum of 4 quarters · filed 2025-02-28 |
| 2023-06-30 | $82.00K 10-Q · filed 2024-08-09 | $592.00K 10-Q · filed 2024-08-09 | $701.00K derived: sum of 3 quarters · filed 2025-02-28 | $1.28M derived: sum of 4 quarters · filed 2025-02-28 |
| 2023-03-31 | $510.00K 10-Q · filed 2024-05-08 | $619.00K derived: sum of 2 quarters · filed 2025-02-28 | $1.20M derived: sum of 3 quarters · filed 2025-02-28 | $1.20M derived: sum of 4 quarters · filed 2025-02-28 |
| 2022-12-31 | $109.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-28 | $690.00K derived: sum of 2 quarters · filed 2025-02-28 | $690.00K derived: sum of 3 quarters · filed 2025-02-28 | $1.42M 10-K · filed 2025-02-28 |
| 2022-09-30 | $581.00K 10-Q · filed 2023-11-09 | $581.00K derived: sum of 2 quarters · filed 2023-11-09 | $1.31M 10-Q · filed 2023-11-09 | $2.38M derived: sum of 4 quarters · filed 2024-03-14 |
| 2022-06-30 | $0.00 10-Q · filed 2023-08-08 | $731.00K 10-Q · filed 2023-08-08 | $1.80M derived: sum of 3 quarters · filed 2024-03-14 | $2.23M derived: sum of 4 quarters · filed 2024-03-14 |
| 2022-03-31 | $731.00K 10-Q · filed 2023-05-09 | $1.80M derived: sum of 2 quarters · filed 2024-03-14 | $2.23M derived: sum of 3 quarters · filed 2024-03-14 | $2.23M derived: sum of 4 quarters · filed 2024-03-14 |
| 2021-12-31 | $1.07M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-14 | $1.49M derived: sum of 2 quarters · filed 2024-03-14 | $1.49M derived: sum of 3 quarters · filed 2024-03-14 | $1.86M 10-K · filed 2024-03-14 |
| 2021-09-30 | $425.00K 10-Q · filed 2022-11-07 | $425.00K derived: sum of 2 quarters · filed 2022-11-07 | $788.00K 10-Q · filed 2022-11-07 | $529.00K derived: sum of 4 quarters · filed 2023-03-03 |
| 2021-06-30 | $0.00 10-Q · filed 2022-08-08 | $363.00K 10-Q · filed 2022-08-08 | $104.00K derived: sum of 3 quarters · filed 2023-03-03 | $380.00K derived: sum of 4 quarters · filed 2023-03-03 |
| 2021-03-31 | $363.00K 10-Q · filed 2022-05-06 | $104.00K derived: sum of 2 quarters · filed 2023-03-03 | $380.00K derived: sum of 3 quarters · filed 2023-03-03 | $713.00K derived: sum of 4 quarters · filed 2023-03-03 |
| 2020-12-31 | -$259.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-03 | $17.00K derived: sum of 2 quarters · filed 2023-03-03 | $350.00K derived: sum of 3 quarters · filed 2023-03-03 | $2.40M 10-K · filed 2023-03-03 |
| 2020-09-30 | $276.00K 10-Q · filed 2021-11-08 | $609.00K derived: sum of 2 quarters · filed 2021-11-08 | $2.66M 10-Q · filed 2021-11-08 | $7.07M derived: sum of 4 quarters · filed 2022-03-01 |
| 2020-06-30 | $333.00K 10-Q · filed 2021-08-09 | $2.38M 10-Q · filed 2021-08-09 | $6.79M derived: sum of 3 quarters · filed 2022-03-01 | $27.73M derived: sum of 4 quarters · filed 2022-03-01 |
| 2020-03-31 | $2.05M 10-Q · filed 2021-05-07 | $6.46M derived: sum of 2 quarters · filed 2022-03-01 | $27.40M derived: sum of 3 quarters · filed 2022-03-01 | $30.23M derived: sum of 4 quarters · filed 2022-03-01 |
| 2019-12-31 | $4.41M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-01 | $25.35M derived: sum of 2 quarters · filed 2022-03-01 | $28.18M derived: sum of 3 quarters · filed 2022-03-01 | $34.34M 10-K · filed 2022-03-01 |
| 2019-09-30 | $20.94M 10-Q · filed 2020-11-06 | $23.77M derived: sum of 2 quarters · filed 2020-11-06 | $29.93M 10-Q · filed 2020-11-06 | $44.04M derived: sum of 4 quarters · filed 2021-03-01 |
| 2019-06-30 | $2.83M 10-Q · filed 2020-08-06 | $9.00M 10-Q · filed 2020-08-06 | $23.10M derived: sum of 3 quarters · filed 2021-03-01 | $20.94M derived: sum of 4 quarters · filed 2021-03-01 |
| 2019-03-31 | $6.16M 10-Q · filed 2020-05-11 | $20.27M derived: sum of 2 quarters · filed 2021-03-01 | $18.11M derived: sum of 3 quarters · filed 2021-03-01 | $62.57M derived: sum of 4 quarters · filed 2021-03-01 |
| 2018-12-31 | $14.10M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-01 | $11.95M derived: sum of 2 quarters · filed 2021-03-01 | $56.41M derived: sum of 3 quarters · filed 2021-03-01 | $56.41M 10-K · filed 2021-03-01 |
| 2018-09-30 | -$2.16M 10-Q · filed 2019-11-07 | $42.31M derived: sum of 2 quarters · filed 2019-11-07 | $42.31M 10-Q · filed 2019-11-07 | $42.31M derived: sum of 4 quarters · filed 2020-03-02 |
| 2018-06-30 | $44.47M 10-Q · filed 2019-08-05 | $44.47M 10-Q · filed 2019-08-05 | $44.47M derived: sum of 3 quarters · filed 2020-03-02 | $44.47M derived: sum of 4 quarters · filed 2020-03-02 |
| 2018-03-31 | $0.00 10-Q · filed 2019-05-09 | $0.00 derived: sum of 2 quarters · filed 2020-03-02 | $0.00 derived: sum of 3 quarters · filed 2020-03-02 | $0.00 derived: sum of 4 quarters · filed 2020-03-02 |
| 2017-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-02 | $0.00 derived: sum of 2 quarters · filed 2020-03-02 | $0.00 derived: sum of 3 quarters · filed 2020-03-02 | $0.00 10-K · filed 2020-03-02 |
| 2017-09-30 | $0.00 10-Q · filed 2018-11-07 | $0.00 derived: sum of 2 quarters · filed 2018-11-07 | $0.00 10-Q · filed 2018-11-07 | |
| 2017-06-30 | $0.00 10-Q · filed 2018-08-09 | $0.00 10-Q · filed 2018-08-09 | ||
| 2016-12-31 | $0.00 10-K · filed 2019-03-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Liquidia Corp (LQDA) | United States | $6.347B | 51.23 |
| RHYTHM PHARMACEUTICALS, INC. (RYTM) | United States | $6.771B | -37.20 |
| Alkermes plc. (ALKS) | $6.844B | 132.74 | |
| Mirum Pharmaceuticals, Inc. (MIRM) | United States | $5.798B | -8.81 |
| Travere Therapeutics, Inc. (TVTX) | United States | $5.712B | -123.10 |
| Oruka Therapeutics, Inc. (ORKA) | United States | $5.663B | -43.76 |
| Cogent Biosciences, Inc. (COGT) | United States | $5.450B | -17.61 |
| IONIS PHARMACEUTICALS INC (IONS) | United States | $7.277B | -23.25 |
| Gossamer Bio, Inc. (GOSS) | United States | $5.355B | -0.65 |
| PTC THERAPEUTICS, INC. (PTCT) | United States | $5.199B | -177.07 |